Daxor Corporation Commences Trading on The NASDAQ Capital Market Management to Ring the Nasdaq Stock Market Opening Bell on February 4, 2022 Oak Ridge, TN, Feb. 02, 2022 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume...

Daxor Corporation Announces $0.48 Per Share NAV Increase and Files Annual Report for Fiscal 2020 Revenues of Operating Division Increase by 50.4% NEW YORK, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) The global leader in blood volume technology today filed its Annual...

BVA Convention to Feature VA Leadership and International Tech Accessible Industry Leaders in Tulsa, Oklahoma. Alexandria, VA, July 31, 2019 (GLOBE NEWSWIRE) -- The Blinded Veteran’s Association’s 74th Annual Convention will be hosted at the Marriot Southern Hills Hotel August 12-16, 2019 in Tulsa, Oklahoma....

New Data Showing Patient Care Individualized by Daxor’s Precision Blood Volume Analysis Reduces Heart Failure Readmissions by 56% and Mortality by over 80% Presented at the American College of Cardiology 2018 Annual Scientific Session (NYSE MKT LLC: DXR) New York, NY, March 14, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with medical instrumentation and biotechnology operations,...